Idiopathic anaphylaxis

Immunology and Allergy Clinics of North America

Volumn 35, Issue 2, 2015, Pages 349-362

  Fenny, Nana ^a   Grammer, Leslie C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Anaphylaxis; Idiopathic anaphylaxis; Mast cell activation syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTIHISTAMINIC AGENT; CETIRIZINE; HISTAMINE; HYDROXYZINE; KETOTIFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PREDNISONE; STEROID;

ANAPHYLAXIS; CLINICAL FEATURE; CORTICOSTEROID DEPENDENT IDIOPATHIC ANAPHYLAXIS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG RESPONSE; EPINEPHRINE AUTOINJECTOR; GENERALIZED DIOPATHIC ANAPHYLAXIS; HISTAMINE RELEASE; HUMAN; IDIOPATHIC ANAPHYLAXIS; IDIOPATHIC ANAPHYLAXIS ANGIOEDEMA; IDIOPATHIC DISEASE; INCIDENCE; LABORATORY TEST; LYMPHOCYTE ACTIVATION; MUNCHAUSEN SYNDROME; PATHOGENESIS; PATIENT EDUCATION; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STRIDOR; SYMPTOM;

ANAPHYLAXIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS;

EID: 84926415979     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2015.01.004     Document Type: Review

References (39)

1. Bacal E., Patterson R., Zeiss C.R. Evaluation of severe (anaphylactic) reactions. Clin Allergy 1978, 8:295-304.
2. Patterson R. Idiopathic anaphylaxis 1997, Oceanside Publications, Inc, Providence (RI).
3. Lieberman P.L. Idiopathic anaphylaxis. Allergy Asthma Proc 2013, 35:17-23.
4. Tanus T., Mines D., Atkins P.C., et al. Serum tryptase in idiopathic anaphylaxis: a case report and review of the literature. Ann Emerg Med 1994, 24:104-107.
5. Webb L., Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 2006, 97:39-43.
6. Moneret-Vautrin D.A., Gay G. The so-called "idiopathic anaphylaxis": allergic and pseudo-allergic reactions. Allerg Immunol (Paris) 1991, 23:89-93. [in French].
7. Greenberger P.A. Idiopathic anaphylaxis. Immunol Allergy Clin North Am 2007, 27:273.
8. Choy C., Patterson R., Patterson D.R., et al. Undifferentiated somatoform idiopathic anaphylaxis: nonorganic symptoms mimicking idiopathic anaphylaxis. JAllergy Clin Immunol 1995, 96:893-900.
9. Tejedor A., Dominguez S., Sanchez-Hernandez J., et al. Clinical and functional differences among patients with idiopathic anaphylaxis. JInvestig Allergol Clin Immunol 2004, 14(3):177-186.
10. Patterson R., Hogan M., Yarnold P., et al. Idiopathic anaphylaxis. Arch Intern Med 1995, 155:869-871.
11. Wood R., Camargo C., Lieberman P., et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. JAllergy Clin Immunol 2014, 133:461-467.
12. Khan D.A., Yocum M.W. Clinical course of idiopathic anaphylaxis. Ann Allergy 1994, 73:370-374.
13. Ditto A.M., Krasnick J., Greenberger P., et al. Pediatric idiopathic anaphylaxis: experience with 22 patients. JAllergy Clin Immunol 1997, 100:320-326.
14. Hogan M.B., Kelly M.A., Wilson N.W. Idiopathic anaphylaxis in children. Ann Allergy Asthma Immunol 1998, 81:140-142.
15. Simons F.E., Ardusso L., Bilo M., et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014, 7:9.
16. Garriga M.M., Firedman M.M., Metcalfe D.D. Asurvey of the number and distribution of mast cells in the skin of patients with mast cell disorders. JAllergy Clin Immunol 1988, 82(3):425-432.
17. Irani A.A., Garriga M.M., Metcalfe D.D., et al. Mast cells in cutaneous mastocytosis: accumulation of the MCTC type. Clin Exp Allergy 1990, 20:53-58.
18. Keffer J., Bressler R.B., Wright R., et al. Analysis of the wheal and flare reactions that follow the intradermal injection of histamine and morphine in adults with recurrent unexplained anaphylaxis and systemic mastocytosis. JAllergy Clin Immunol 1989, 83:595.
19. Sonin L., Grammer L.C., Greenberger P.A., et al. Idiopathic anaphylaxis: a clinical summary. Ann Intern Med 1983, 99:634.
20. Tedeschi A., Lorini M., Suli C., et al. Detection of serum histamine-releasing factors in a patient with idiopathic anaphylaxis and multiple drug allergy syndrome. JInvestig Allergol Clin Immunol 2007, 17(2):122-125.
21. Grammer L.C., Shaughnessy M.A., Harris K.E., et al. Lymphocyte subsets and activation markers in patients with acute episodes of idiopathic anaphylaxis. Ann Allergy Asthma Immunol 2000, 85:368-371.
22. Gruber B.L., Baeza M.L., Marchese M.J., et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. JInvest Dermatol 1988, 90:213.
23. Ditto A.M., Harris K.E., Krasnick J., et al. Idiopathic anaphylaxis: a series of 335 cases. Ann Allergy Asthma Immunol 1996, 77:285-291.
24. Pumphrey R.S. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000, 30:114-150.
25. Bahna S.L., Oldham J.L. Munchausen stridor-a strong false alarm of anaphylaxis. Allergy Asthma Immunol Res 2014, 6:577-579.
26. Tripathi A., Commins S.P., Heymann P.W., et al. Delayed anaphylaxis to red meat masquerading as idiopathic anaphylaxis. JAllergy Clin Immunol Pract 2014, 2(3):259-265.
27. Stey C., Jost R., Ammann R. Recurrent life-threatening anaphylaxis as initial manifestation of cystic echinococcosis (granulosus) of the liver. Schweiz Med Wochenschr 1993, 123(29):1445-1447.
28. Akin C., Scott L., Kocabas C. Demonstration of an aberrant mast cell population with clonal markers in a subset of patients with idiopathic anaphylaxis. Blood 2007, 110(7):233.
29. Kaliner M., Dyer J., Merlins S., et al. Increased urinary histamine in contrast media reactions. Invest Radiol 1984, 19:116.
30. Shanmugam G., Schwartz L.B., Khan D.A. Prolonged elevation of serum tryptase in idiopathic anaphylaxis. JAllergy Clin Immunol 2006, 117:950-951.
31. Sristava S., Huissoon A.P., Barrett V., et al. Systemic reactions and anaphylaxis with an acute serum tryptase ≥14 μg/L: retrospective characterisation of aetiology, severity and adherence to National Institute of Health and Care Excellence (NICE) guidelines for serial tryptase measurements and specialist referral. JClin Pathol 2014, 67:614-619.
32. Stricker W.E., Anorve Lopez E., Reed C.E. Food skin testing in patients with idiopathic anaphylaxis. JAllergy Clin Immunol 1986, 77(3):516-519.
33. Heaps A., Carter S., Selwood C., et al. The utility of the ISAC allergen array in the investigation of idiopathic anaphylaxis. Clin Exp Immunol 2014, 177(2):483-490.
34. Patterson R., Stoloff R.F., Greenberger P.A., et al. Algorithms for the diagnosis and management of idiopathic anaphylaxis. Ann Allergy 1993, 71:40-44.
35. Patterson R., Fitzsimons E.J., Choy C., et al. Malignant and corticosteroid-dependent idiopathic anaphylaxis: successful responses to ketotifen. Ann Allergy Asthma Immunol 1997, 79:138-144.
36. Jones J.D., Marney S.R., Fahrenholz J.M. Idiopathic anaphylaxis successfully treated with omalizumab. Ann Allergy Asthma Immunol 2008, 101:550-551.
37. Lee J. Successful prevention of recurrent anaphylactic events with anti-immunoglobulin E therapy. Asia Pac Allergy 2014, 4:126-128.
38. Alonso T., Garcia M., Hernandez J. Recurrence of anaphylaxis in a Spanish series. JInvestig Allergol Clin Immunol 2013, 23(6):383-391.
39. Krasnick J., Patterson R., Meyers G. Afatality from idiopathic anaphylaxis. Ann Allergy Asthma Immunol 1996, 76:376-379.